Pyridostigmine Bromide (PYR) Alters Immune Function in B6C3F1 Mice

Immunopharmacology and Immunotoxicology

Volumn 26, Issue 1, 2004, Pages 1-15

  Peden Adams, M M ^a,b   Dudley, A C ^b   EuDaly, J G ^b   Allen, C T ^b   Gilkeson, G S ^a,b,c   Keil, D E ^b,d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Gulf War Illness; IgM antibody responses; Immunotoxicity; Pyridostigmine bromide

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CD4 ANTIGEN; CD8 ANTIGEN; CHOLINESTERASE INHIBITOR; DEXAMETHASONE; IMMUNOGLOBULIN M ANTIBODY; PYRIDOSTIGMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EVALUATION; FEMALE; IMMUNE RESPONSE; IMMUNOTOXICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; ORGAN WEIGHT; PLAQUE FORMING CELL; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; THYMUS;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODY FORMATION; BODY WEIGHT; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CONCANAVALIN A; CYTOTOXICITY, IMMUNOLOGIC; DEXAMETHASONE; ERYTHROCYTES; FEMALE; IMMUNITY; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; ORGAN SIZE; PYRIDOSTIGMINE BROMIDE; SPLEEN; TETRACHLORODIBENZODIOXIN; THYMUS GLAND; VACCINATION;

ANIMALIA;

EID: 1942519885     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120029939     Document Type: Article

References (56)

1. Drachman, D.B. Myasthenia gravis. In Harrison's Principles of Internal Medicine, 12th Ed.; Wilson, J.D., Braunwald, E., Fauci, A.S., Eds.; McGraw-Hill Book Company: New York, 1990; 2118-2120.
2. Breyer-Pfaff, U.; Schmezer, A.; Maier, U. Neuromuscular function and plasma drug levels in pyridostigmine treatment of myasthenia gravis. J. Neurol. Neurosurg. Psychiatry 1990, 53, 502-506.
3. Keeler, J.R.; Hurst, C.G.; Dunn, M.A. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA 1991, 266, 693-695.
4. Dunn, M.A.; Sidell, M.D. Progress in medical defense against nerve agents. JAMA 1989, 262, 649-652.
5. Gavaghan, H. NIH panel rejects Persian Gulf syndrome. Nature 1994, 369, 8.
6. Wenger, C.B.; Quigley, M.D.; Kolka, M.A. Seven-day pyridostigmine administration and thermoregulation during rest and exercise in dry heat. Aviat. Space Environ. Med. 1993, 64, 905-911.
7. Kemp, K.H.; Wetherell, A. A Lab Study of the Performance of Men Taking Pyridostigmine Bromide Orally for Two Weeks; Technical Note #494, Chemical Defense Establishment: Porton Down, UK, 1991.
8. Cook, J.E.; Kloka, M.A.; Wenger, C.B. Chronic pyridostigmine bromide administration: side effects among soldiers working in a desert environment. Mil. Med. 1992, 157, 250-254.
9. Prusaczyk, W.; Sawka, M.N. Effects of pyridostigmine bromide on human thermoregulation during cold water immersion. J. Appl. Physiol. 1991, 71, 432-437.
10. Wenger, C.B.; Latzka, W.A. Effects of pyridostigmine bromide on physiological responses to heat, exercise, and hypohydration. Aviat. Space Environ. Med. 1992, 63, 37-45.
11. Chaney, L.A.; Rockhold, R.W.; Mozingo, J.R.; Hume, A.S. Potentiation of pyridostigmine bromide toxicity in mice by selected adrenergic agents and caffeine. Vet. Hum. Toxicol. 1997, 39 (4), 214-219.
12. Abou-Donia, M.B.; Jensen, K.F.; Oehme, F.W.; Kurt, T.L. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET and permethrin: implication of Gulf War chemical exposures. J. Toxicol. Environ. Health 1996, 48, 35-56.
13. McCain, W.C.; Lee, R.; Johnson, M.S.; Whaley, J.E.; Ferguson, J.W.; Beall, P.; Leach, G. Acute oral toxicity study of pyridostigmine bromide, permethrin, and DEET in the laboratory rat. J. Toxicol. Environ. Health 1997, 50, 113-124.
14. Abou-Donia, M.B.; Wilmarth, K.R.; Abdel-Rahman, A.A.; Jensen, K.F.; Oehme, F.W.; Durt, T.L. Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos. Fundam. Appl. Toxicol. 1996, 34, 201-222.
15. Gouge, S.F.; Daniels, D.J. Exacerbation of asthma after pyridostigmine during Operation Desert Storm. Mil. Med. 1994, 159, 109-111.
16. Mirakhur, R.K.; Lavery, T.D.; Briggs, L.P.; Clarke, R.S. Effects of neostigmine and pyridostigmine on serum cholinesterase activity. Can. Anaesth. Soc. J. 1982, 20 (1), 55-59.
17. Anderson, R.J.; Chamberlain, W.L.; Roesner, M.; Dacko, C.; Robertson, D.G. Decreased tetanic contracture of rat skeletal muscle induced by pyridostigmine. J. Toxicol. Environ. Health 1986, 18 (2), 221-230.
18. Bowman, P.D.; Schuschereba, S.T.; Johnson, T.W.; Woo, F.J.; McKinney, L. ; Wheeler, C.R.; Frost, D.; Korte, D.W. Myopathic changes in diaphragm of rats fed pyridostigmine bromide subchronically. Fundam. Appl. Toxicol. 1989, 13 (1), 110-117.
19. Harris, G.L.; Maibach, H.I. Allergic contact dermatitis potential of 3 pyridostigmine bromide transdermal drug delivery formulations. Contact Dermatitis 1989, 21, 189-193.
20. Levine, B.S.; Waller, D.P.; Long, R.; Parker, R.; Denny, K.; Chung, H. Subchronic and reproductive toxicity studies on pyridostigmine bromide. J. Am. Coll. Toxicol. 1989, 8 (6), 1209.
21. Levine, B.S.; Parker, R.N. Reproductive and developmental toxicity studies of pyridostigmine bromide in rats. Toxicology 1991, 69 (3), 291-300.
22. Trainer, P.J.; Kirk, J.M.; Savage, M.O.; Grossman, A.B.; Besser, G.M. Pyridostigmine partially reversed dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone. J. Endocrinol. 1992, 134 (3), 513-517.
23. Cappa, M.; Grossi, A.; Benedetti, S.; Drage, F.; Loche, S.; Ghigo, E. Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man. J. Endocrinol. Invest. 1993, 16 (6), 421-424.
24. Babu, S.R.; Somani, S.M.; Dube, S.N. Effect of physostigmine and exercise on choline acetyltransferase and acetylcholinesterase activities in fast and slow muscles of rat. Pharmacol. Biochem. Behav. 1993, 45 (3), 713-717.
25. Lorente, I.; Lizcano, F.; Alvarez, R.; Diez, N.; Sopena, M.; Gil, M.J.; Salvador, J. Cholinergic modulation of spontaneous hypothalamic-pituitary-adrenal activity and its circadian variation in man. J. Clin. Endocrinol. Metab. 1996, 81 (8), 2902-2907.
26. Leo K.U. Metabolism of proposed nerve agent pretreatment, pyridostigmine bromide. Gov. Rep. Announce. Index 1997, 17.
27. Rook, G.A.W.; Zumler, A. Gulf War syndrome: is it due to a symptomatic shift in cytokine balance towards a Th2 profile? Lancet 1997, 349, 1831-1833.
28. Everson, M.P.; Kotler, S.; Blackburn, W.D. Stress and immune dysfunction in Gulf War veterans. Ann. N. Y. Acad. Sci. 1999, 876, 413-418.
29. Moss, J.I. Many Gulf War illnesses may be autoimmune disorders caused by the chemical and biological stressors pyridostigmine bromide and adrenaline. Med. Hypotheses 2001, 56, 155-157.
30. Duke, S.S.; Schook, L.B.; Holsapple, M.P. Effects of N-nitrodimethylamine on tumor susceptibility. J. Leukoc. Biol. 1985, 37, 383-394.
31. Holsapple, M.P.; White, K.L.; McCay, J.A.; Bradley, S.G.; Munson, A.E. An immunotoxicological evaluation of 4,4′-thiobis-(6-t-butyl-m-cresol) in female B6C3F1 mice. 2. Humoral and cell-mediated immunity, macrophage function, and host resistance. Fundam. Appl. Toxicol. 1988, 10, 701-716.
32. Bryant, J.; Day, R.; Whiteside, T.L.; Herberman, R.B. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J. Immunol. Methods 1992, 146, 91-103.
33. Jerne, N.K.; Nordin, A.A. Plaque formation in agar by single antibody producing cells. Science 1963, 140, 405.
34. Cunningham, A.J.; Szenberg, A. Further improvements in the plaque forming technique for detecting single antibody forming cells. Immunology 1968, 14, 599-601.
35. Harper, N.; Howie, L.; Connor, K.; Dickerson, R.; Safe, S. Immunosuppressive effects of highly chlorinated biphenyls and diphenyl ethers on T-cell dependent and independent antigens in mice. Toxicology 1993, 85 (2-3), 123-135.
36. Casale, G.P.; Vennerstrom, J.L.; Bavari, S.; Wang, T.L. Inhibition of interleukin 2 driven proliferation of mouse CTLL2 cells, by selected carbamate and organophosphate insecticides and congeners of carbaryl. Immunopharmacol. Immunotoxicol. 1993, 15 (2-3), 199-215.
37. Altman, A.; Mustelin, T.; Coggeshall, K.M. T lymphocyte activation: a biological mode of signal transduction. Crit. Rev. Immunol. 1990, 10, 347-391.
38. Isakov, N.; Bleackley, R.C.; Shaw, J.; Altman, A. Teleocidin and phorbol ester tumor promoter exert similar mitogenic effects on human lymphocytes. Biochem. Biophys. Res. Commun. 1985, 130, 724-731.
39. Casale, G.P.; Bavari, S.; Gold, R.E.; Vitzthum, E.F. Inhibition of interleukin-2-stimulated enhancement of human natural killer (NK) cell activity by carbaryl, an anticholinesterase insecticide. Toxicol. Lett. 1992, 63 (3), 299-311.
40. Gorelik, E.; Herberman, R.B. Inhibition of the activity of mouse natural killer cells by urethane. J. Natl. Cancer Inst. 1981, 66 (3), 543-548.
41. Luster, M.I.; Dean, J.H.; Boorman, G.A.; Dieter, M.P.; Hayes, H.T. Immune functions in methyl and ethyl carbamate treated mice. Clin. Exp. Immunol. 1982, 50 (1), 223-230.
42. Flipo, D.; Bernier, J.; Girard, D.; Krzystyniak, K.; Fournier, M. Combined effects of selected insecticides on humoral immune response in mice. Int. J. Immunopharmacol. 1992, 14 (5), 747-752.
43. Cha, S.W.; Gu, H.K.; Lee, K.P.; Lee, M.H.; Han, S.S.; Jeong, T.C. Immunotoxicity of ethyl carbamate in female BALB/c mice: role of esterase and cytochrome P450. Toxicol. Lett. 2000, 115 (3), 173-181.
44. Ladics, G.S.; Smith, C.; Heaps, K.; Loveless, S.E. Evaluation of the humoral immune response of CD rats following a 2-week exposure to the pesticide carbaryl by the oral, dermal, or inhalation routes. J. Toxicol. Environ. Health 1994, 42 (2), 143-156.
45. Olson, L.J.; Erickson, B.J.; Hinsdill, R.D.; Wyman, J.A.; Porter, W.P.; Binning, L.K.; Bidgood, R.C.; Nordheim, E.V. Aldicarb immunomodulation in mice: an inverse dose-response to parts per billion levels in drinking water. Arch. Environ. Contam. Toxicol. 1987, 16, 433-439.
46. Thomas, P.T.; Ratajczak, H.V.; Eisenberg, W.C.; Furedi-Machacek, M.; Ketels, K.V.; Barbera, P.W. Evaluation of host resistance and immunity in mice exposed to the carbamate pesticide aldicarb. Fundam. Appl. Toxicol. 1987, 9, 82-89.
47. Thomas, P.T.; Ratajczak, H.V.; Demetral, D.; Hagen, K.; Baron, R. Aldicarb immunotoxicology: functional analysis of cell-mediated immunity and quantitation of lymphocyte subpopulations. Fundam. Appl. Toxicol. 1990, 15, 221-230.
48. Gilkeson, G.S.; Peden-Adams, M.M.; EuDaly, J.G.; Dabra, S.; EuDaly, A.; Hayes, R.; Heesemann, L.; Miller, J.; Smythe, J.; Keil, D.E. Exposure to single or tertiary mixtures of N,N-diethyl-m-toluamide (DEET), pyridostigmine bromide (PYR), JP-8 jet fuel and stress in autoimmune-prone mice. Toxicologist 2002, 66, 79.
49. Peden-Adams, M.M.; EuDaly, J.; EuDaly, E.; Dudley, A.; Zeigler, J.; Lee, A.; Robbs, J.; Gilkeson, G.; Keil, D.E. Evaluation of immunotoxicity induced by single or concurrent exposure to N,N-diethyl-m-toluamide, pyridostigmine bromide and JP-8 jet fuel. Toxicol. Ind. Health 2001, 17, 192-209.
50. Griffiths, G.D.; Hornby, R.J.; Stevens, D.J.; Scott, L.A.M.; Upshall, D.G. Biological consequences of multiple vaccine and pyridostigmine pretreatment in the guinea pig. J. Appl. Toxicol. 2001, 21, 59-68.
51. Somani, S.M.; Roberts, J.B.; Wilson, A. Pyridostigmine metabolism in man. Clin. Pharmacol. Ther. 1972, 13, 393-399.
52. Song, X.; Tian, H.; Bressler, J.; Pruett, S.; Pope, C. Acute and repeated restraint stress have little effect on pyridostigmine toxicity or brain regional cholinesterase inhibition in rats. Toxicol. Sci. 2002, 69, 157-164.
53. Bernatova, I.; Dubovicky, M.; Price, W.A.; Grubbs, R.D.; Lucot, J.B.; Morris, M. Effect of chronic pyridostigmine bromide treatment on cardiovascular and behavioral parameters in mice. Pharmacol. Biochem. Behav. 2003, 74, 901-907.
54. Somani, S.M.; Husain, K.; Asha, T.; Helfert, R. Interactive and delayed effects of pyridostigmine and physical stress on biochemical and histological changes in peripheral tissues of mice. J. Appl. Toxicol. 2000, 20, 327-334.
55. Everson, M.P.; Shi, K.; Aldridge, P.; Bartolucci, A.A.; Blackburn, W.D. Immunological responses are not abnormal in symptomatic Gulf War veterans. Ann. N. Y. Acad. Sci. 2002, 966, 327-342.
56. Bregenholt, S.; Ishoy, T.; Skovgaard, L.T.; Suadicani, P.; Appleyard, M. ; Guldager, B.; Malte, L.; Gyntelberg, F.; Claesson, M.H. No evidence for altered cellular immune functions in personnel deployed in the Persian Gulf during and after the Gulf War - The Danish Gulf War study. APMIS 2001, 109, 517-524.